J7320 Genvisc 850, injection, 1mg
Also known as: Genvisc 850, hyaluronic acid, sodium hyaluronate
Injection of Genvisc 850 (sodium hyaluronate), 1 milligram, a high-molecular-weight hyaluronic acid viscosupplement.
In Plain Language
joint lubrication injection; arthritis treatment
Clinical Context
Used for intra-articular viscosupplementation in osteoarthritis to improve joint lubrication and reduce pain.
RVU Information
CPT J7320 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7320?
CPT J7320 (Genvisc 850, injection, 1mg) is a J Codes (Drugs) code. Injection of Genvisc 850 (sodium hyaluronate), 1 milligram, a high-molecular-weight hyaluronic acid viscosupplement.
How is J7320 administered?
CPT J7320 is administered by a healthcare provider, typically via injection or infusion. Used for intra-articular viscosupplementation in osteoarthritis to improve joint lubrication and reduce pain. It is used by Orthopedic Surgery, Rheumatology, Physical Medicine and Rehabilitation.
When is CPT J7320 used?
Used for intra-articular viscosupplementation in osteoarthritis to improve joint lubrication and reduce pain.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.